Also add to that after the 12 month delay to the oxymorphone patch puts POH to only $6m cash left of the $19 mill raised to trial the patch.
It will be begging bowl time again mid next year and still no trial commenced. It seems injectibles is not immenient. Seems like something with that is drifting well into next year, if at all.
So I must agree with Playez, it is down to the oxycodone topical to have a result that captures the attention of investors and pharma and wallets in the next 6 months, or it is looking grim.
.
Phosphagenics Emerges Strongly From Fraud Cloud, page-3
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $95.58K | 47.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 58466742 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 15489231 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |